{"transactions":[{"id":4633505,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-10-02T02:16:03.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":250,"derivative":{"exercise_price":1.95,"exercise_date":"2026-09-30","expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001213900-26-105952","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390026105952/ownership.xml","form_type":"4"}},{"id":719074,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-07-02T20:31:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":250,"derivative":{"exercise_price":4.88,"exercise_date":"2026-06-30","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001213900-26-075026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390026075026/ownership.xml","form_type":"4"}},{"id":743034,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T17:37:49.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":107159,"source":{"system":"sec-edgar","filing":"0001628280-26-042129","document":"wk-form4_1781113066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828026042129/wk-form4_1781113066.xml","form_type":"4"}},{"id":812854,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-04-08T21:01:56.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":250,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":250,"derivative":{"exercise_price":4.55,"exercise_date":"2026-03-31","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":250},"source":{"system":"sec-edgar","filing":"0001213900-26-041562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390026041562/ownership.xml","form_type":"4"}},{"id":953056,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-01-06T00:06:57.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":0.36,"exercise_date":"2025-12-31","expiration_date":"2035-12-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-26-001370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390026001370/ownership.xml","form_type":"4"}},{"id":1028098,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-10-03T00:34:55.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":0.7,"exercise_date":"2025-09-30","expiration_date":"2035-09-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-25-095755","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390025095755/ownership.xml","form_type":"4"}},{"id":1096218,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-07-02T10:01:17.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":0.68,"exercise_date":"2025-06-30","expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-25-060673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390025060673/ownership.xml","form_type":"4"}},{"id":1113228,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:33:22.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":9868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":72642,"source":{"system":"sec-edgar","filing":"0001628280-25-031019","document":"wk-form4_1749760393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828025031019/wk-form4_1749760393.xml","form_type":"4"}},{"id":1120330,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-06T20:05:21.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001641172-25-014017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225014017/ownership.xml","form_type":"4"}},{"id":1120329,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:05:21.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":73989,"source":{"system":"sec-edgar","filing":"0001641172-25-014017","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225014017/ownership.xml","form_type":"4"}},{"id":1184793,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T12:23:47.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4."}],"balance_after":5312,"derivative":{"underlying":"Common Stock","underlying_shares":5313},"source":{"system":"sec-edgar","filing":"0001641172-25-002278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002278/ownership.xml","form_type":"4"}},{"id":1184792,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T12:23:47.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":68677,"source":{"system":"sec-edgar","filing":"0001641172-25-002278","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225002278/ownership.xml","form_type":"4"}},{"id":1186959,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-04-01T21:00:06.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.1,"exercise_date":"2025-03-31","expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-25-027217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390025027217/ownership.xml","form_type":"4"}},{"id":1307135,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-01-08T23:17:17.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001562180-25-000277","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218025000277/primarydocument.xml","form_type":"4"}},{"id":1307134,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-08T23:17:17.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,312 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":63364,"source":{"system":"sec-edgar","filing":"0001562180-25-000277","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218025000277/primarydocument.xml","form_type":"4"}},{"id":1316267,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-01-03T21:00:08.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.39,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-25-000732","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390025000732/ownership.xml","form_type":"4"}},{"id":1392707,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-10-03T20:44:55.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":false,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4."}],"balance_after":15937,"derivative":{"underlying":"Common Stock","underlying_shares":5313},"source":{"system":"sec-edgar","filing":"0001562180-24-007233","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218024007233/primarydocument.xml","form_type":"4"}},{"id":1392706,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-03T20:44:55.000Z","date":"2024-09-30","kind":"exercise","planned":false,"acquired":true,"shares":5313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 21,250 RSUs, 5,313 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024."}],"balance_after":58052,"source":{"system":"sec-edgar","filing":"0001562180-24-007233","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218024007233/primarydocument.xml","form_type":"4"}},{"id":1395253,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-10-02T10:21:18.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":2.28,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-084302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024084302/ownership.xml","form_type":"4"}},{"id":1423602,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-26T20:42:10.000Z","date":"2024-08-22","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer\nthrough the applicable vesting dates."}],"balance_after":21250,"derivative":{"underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0000950170-24-100573","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024100573/ownership.xml","form_type":"4"}},{"id":1435253,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:15:54.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":16593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock represent restricted stock units with the contingent right to receive one share of common stock of Aspira Women's Health Inc. for each restricted stock unit. The restricted stock unit vested in full on August 12, 2024."}],"balance_after":52739,"source":{"system":"sec-edgar","filing":"0000950170-24-096244","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024096244/ownership.xml","form_type":"4"}},{"id":1457102,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to buy)","published_at":"2024-07-10T20:31:41.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":3268,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53."}],"balance_after":3268,"derivative":{"exercise_price":2.25,"exercise_date":"2024-07-09","expiration_date":"2027-07-09","underlying":"Common Stock, par value $0.001","underlying_shares":3268},"source":{"system":"sec-edgar","filing":"0000950170-24-082709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024082709/ownership.xml","form_type":"4"}},{"id":1457101,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-10T20:31:41.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":3268,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53."}],"balance_after":36146,"source":{"system":"sec-edgar","filing":"0000950170-24-082709","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000095017024082709/ownership.xml","form_type":"4"}},{"id":1463924,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-07-02T21:56:07.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.56,"exercise_date":"2024-06-30","expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-058705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024058705/ownership.xml","form_type":"4"}},{"id":1483354,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-11T21:49:49.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":false,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-24-027715","document":"wk-form4_1718142583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027715/wk-form4_1718142583.xml","form_type":"4"}},{"id":1483353,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:49:49.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":13286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":62774,"source":{"system":"sec-edgar","filing":"0001628280-24-027715","document":"wk-form4_1718142583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027715/wk-form4_1718142583.xml","form_type":"4"}},{"id":1483352,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T21:49:49.000Z","date":"2024-06-05","kind":"exercise","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":49488,"source":{"system":"sec-edgar","filing":"0001628280-24-027715","document":"wk-form4_1718142583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828024027715/wk-form4_1718142583.xml","form_type":"4"}},{"id":1554511,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-04-03T01:36:03.000Z","date":"2024-03-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.95,"exercise_date":"2024-03-31","expiration_date":"2034-03-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-029547","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024029547/ownership.xml","form_type":"4"}},{"id":1696984,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-01-03T00:13:36.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.78,"exercise_date":"2023-12-29","expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-000366","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390024000366/ownership.xml","form_type":"4"}},{"id":1768540,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-10-03T10:09:35.000Z","date":"2023-09-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.16,"exercise_date":"2023-09-30","expiration_date":"2033-09-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001013762-23-000714","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101376223000714/ownership.xml","form_type":"4"}},{"id":1801809,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:29:34.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":10061,"derivative":{"underlying":"Common Stock","underlying_shares":10061},"source":{"system":"sec-edgar","filing":"0001628280-23-029926","document":"wk-form4_1692365366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029926/wk-form4_1692365366.xml","form_type":"4"}},{"id":1801808,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-08-18T13:29:34.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":false,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001628280-23-029926","document":"wk-form4_1692365366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029926/wk-form4_1692365366.xml","form_type":"4"}},{"id":1801807,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-18T13:29:34.000Z","date":"2023-06-07","kind":"exercise","planned":false,"acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":39427,"source":{"system":"sec-edgar","filing":"0001628280-23-029926","document":"wk-form4_1692365366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023029926/wk-form4_1692365366.xml","form_type":"4"}},{"id":1823027,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-26T20:28:42.000Z","date":"2023-07-24","kind":"purchase","planned":false,"acquired":true,"shares":3769,"price":3.98,"value":15000.62,"ownership":{"direct":true},"balance_after":32878,"source":{"system":"sec-edgar","filing":"0000926617-23-000061","document":"certent-form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000061/certent-form4.xml","form_type":"4"}},{"id":1837427,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-07-05T21:30:20.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":0.93,"exercise_date":"2023-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-23-054870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390023054870/ownership.xml","form_type":"4"}},{"id":1868104,"issuer":{"id":7871,"kind":"organization","name":"Aspira Women's Health Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T21:05:06.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":29109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"6,509 of the restricted stock units will vest on June 1, 2023, 11,300 of the restricted stock units will vest on September 1, 2023 and 11,300 of the restricted stock units will vest on December 1, 2023."}],"balance_after":29109,"source":{"system":"sec-edgar","filing":"0001562180-23-004817","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/926617/000156218023004817/primarydocument.xml","form_type":"4"}},{"id":1932918,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-04-03T19:36:04.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":1.44,"value":10800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":1.44,"exercise_date":"2023-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-23-026199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000121390023026199/ownership.xml","form_type":"4"}},{"id":1932254,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-04-03T16:18:04.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001628280-23-010319","document":"wf-form4_168053867340398.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010319/wf-form4_168053867340398.xml","form_type":"4"}},{"id":1932253,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-03T16:18:04.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":34790,"source":{"system":"sec-edgar","filing":"0001628280-23-010319","document":"wf-form4_168053867340398.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023010319/wf-form4_168053867340398.xml","form_type":"4"}},{"id":2067107,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-01-04T21:06:26.000Z","date":"2022-12-30","kind":"exercise","acquired":false,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On December 30, 2021 the reporting person was granted 409 restricted stock units which vested in full on December 30, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001628280-23-000213","document":"wf-form4_167286634698904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000213/wf-form4_167286634698904.xml","form_type":"4"}},{"id":2067106,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:06:26.000Z","date":"2022-12-30","kind":"exercise","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":34133,"source":{"system":"sec-edgar","filing":"0001628280-23-000213","document":"wf-form4_167286634698904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828023000213/wf-form4_167286634698904.xml","form_type":"4"}},{"id":2073183,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-01-03T21:36:33.000Z","date":"2022-12-31","kind":"grant","acquired":true,"shares":7500,"price":2.14,"value":16050.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":2.14,"exercise_date":"2022-12-31","expiration_date":"2032-12-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001019056-23-000012","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905623000012/vos.xml","form_type":"4"}},{"id":2147856,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2022-10-03T18:53:22.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":7500,"price":4.34,"value":32550.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":7500,"derivative":{"exercise_price":4.34,"exercise_date":"2022-09-30","expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001019056-22-000617","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000617/vos.xml","form_type":"4"}},{"id":2148649,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-30T20:37:34.000Z","date":"2022-09-29","kind":"exercise","acquired":false,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001628280-22-025807","document":"wf-form4_166457022239063.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025807/wf-form4_166457022239063.xml","form_type":"4"}},{"id":2148648,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-30T20:37:34.000Z","date":"2022-09-29","kind":"exercise","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":33724,"source":{"system":"sec-edgar","filing":"0001628280-22-025807","document":"wf-form4_166457022239063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000162828022025807/wf-form4_166457022239063.xml","form_type":"4"}},{"id":2181503,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T20:45:42.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":500,"price":15.91,"value":7955.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001213900-22-049031","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022049031/ownership.xml","form_type":"4"}},{"id":2192182,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2022-08-08T20:23:31.000Z","date":"2022-07-19","kind":"grant","acquired":true,"shares":1648,"price":5.16,"value":8503.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\""}],"balance_after":1648,"derivative":{"exercise_price":5.16,"exercise_date":"2022-07-19","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":1648},"source":{"system":"sec-edgar","filing":"0001019056-22-000548","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905622000548/vos.xml","form_type":"4"}},{"id":2234092,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-13T20:45:16.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":4637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders."}],"balance_after":4637,"derivative":{"underlying":"Common Stock","underlying_shares":4637},"source":{"system":"sec-edgar","filing":"0001213900-22-032532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022032532/ownership.xml","form_type":"4"}},{"id":2311110,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T20:46:34.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":657,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on March 30, 2023."}],"balance_after":657,"derivative":{"underlying":"Common Stock","underlying_shares":657},"source":{"system":"sec-edgar","filing":"0001213900-22-017499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022017499/ownership.xml","form_type":"4"}},{"id":2454166,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-03T21:45:16.000Z","date":"2021-12-30","kind":"grant","acquired":true,"shares":409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":743,"derivative":{"underlying":"Common Stock","underlying_shares":409},"source":{"system":"sec-edgar","filing":"0001213900-22-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390022000277/ownership.xml","form_type":"4"}},{"id":2531005,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-01T23:52:41.000Z","date":"2021-10-28","kind":"purchase","acquired":true,"shares":55555,"price":2.7,"value":149998.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On October 28, 2021, the reporting person entered into a common stock purchase agreement with the Issuer and purchased 55,555 shares of the Company's common stock, par value $0.001 per share, at the closing market price on October 28, 2021 of $2.70 per share."}],"balance_after":61562,"source":{"system":"sec-edgar","filing":"0001019056-21-000555","document":"vos.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000555/vos.xml","form_type":"4"}},{"id":2554277,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T20:45:17.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on September 29, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":334,"derivative":{"underlying":"Common Stock","underlying_shares":334},"source":{"system":"sec-edgar","filing":"0001213900-21-051139","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021051139/ownership.xml","form_type":"4"}},{"id":2602751,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to purchase common stock","published_at":"2021-08-16T18:46:02.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":1087354,"price":4.06,"value":4414657.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Twenty percent of the shares subject to the option vest after six months with the remaining shares subject to the option vesting in equal monthly amounts over the next 42 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\" As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 1,143,361 shares of the Issuer."}],"balance_after":1087354,"derivative":{"exercise_price":4.06,"exercise_date":"2022-02-11","expiration_date":"2031-08-11","underlying":"Common Stock","underlying_shares":1087354},"source":{"system":"sec-edgar","filing":"0001019056-21-000477","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000477/vos.xml","form_type":"4"}},{"id":2645717,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-07-02T19:40:27.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":6007,"price":5.9,"value":35441.3,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the \"class\" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same \"class.\" As a result of the grant reported herein, the Reporting Person currently has aggregate options to purchase a total of 56,007 shares of the Issuer."}],"balance_after":6007,"derivative":{"exercise_price":5.9,"exercise_date":"2021-06-30","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":6007},"source":{"system":"sec-edgar","filing":"0001019056-21-000407","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000407/vos.xml","form_type":"4"}},{"id":2649699,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-30T20:49:26.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":32890,"source":{"system":"sec-edgar","filing":"0001213900-21-035082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021035082/ownership.xml","form_type":"4"}},{"id":2703772,"issuer":{"id":7488,"kind":"organization","name":"Modular Medical, Inc."},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-05-20T21:01:44.000Z","date":"2021-05-18","kind":"grant","acquired":true,"shares":50000,"price":4.95,"value":247500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This option will vest as to one-third of the shares subject to the option on each annual anniversary of May 18, 2021."}],"balance_after":50000,"derivative":{"exercise_price":4.95,"exercise_date":"2022-05-18","expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001019056-21-000316","document":"vos.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1074871/000101905621000316/vos.xml","form_type":"4"}},{"id":2761114,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-02T16:42:19.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":32483,"source":{"system":"sec-edgar","filing":"0001213900-21-019882","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021019882/ownership.xml","form_type":"4"}},{"id":2920119,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:46:24.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":31944,"source":{"system":"sec-edgar","filing":"0001213900-21-000457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000457/ownership.xml","form_type":"4"}},{"id":2920118,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:46:24.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":1183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":31142,"source":{"system":"sec-edgar","filing":"0001213900-21-000457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390021000457/ownership.xml","form_type":"4"}},{"id":3091672,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T20:36:26.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":1937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":29959,"source":{"system":"sec-edgar","filing":"0001213900-20-016585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/ownership.xml","form_type":"4"}},{"id":3189079,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-01T16:10:56.000Z","date":"2020-03-31","kind":"purchase","acquired":true,"shares":1000,"price":8.75,"value":8750.0,"ownership":{"direct":true},"balance_after":28022,"source":{"system":"sec-edgar","filing":"0001213900-20-008316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/ownership.xml","form_type":"4"}},{"id":3190856,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-31T12:46:35.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":2784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":27022,"source":{"system":"sec-edgar","filing":"0001213900-20-008138","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/ownership.xml","form_type":"4"}},{"id":3316263,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T21:31:22.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":24238,"source":{"system":"sec-edgar","filing":"0001213900-20-000385","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390020000385/ownership.xml","form_type":"4"}},{"id":3371222,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T16:23:45.000Z","date":"2019-11-13","kind":"purchase","acquired":true,"shares":600,"price":9.62,"value":5772.0,"ownership":{"direct":true},"balance_after":22154,"source":{"system":"sec-edgar","filing":"0001213900-19-023370","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019023370/ownership.xml","form_type":"4"}},{"id":3400988,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T21:18:10.000Z","date":"2019-09-30","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":21554,"source":{"system":"sec-edgar","filing":"0001213900-19-019545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019019545/ownership.xml","form_type":"4"}},{"id":3574031,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-29T20:23:27.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":17386,"source":{"system":"sec-edgar","filing":"0001213900-19-005248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390019005248/ownership.xml","form_type":"4"}},{"id":3793490,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-10T21:20:58.000Z","date":"2018-10-08","kind":"purchase","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":15302,"source":{"system":"sec-edgar","filing":"0001213900-18-013770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018013770/ownership.xml","form_type":"4"}},{"id":3874874,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T18:43:55.000Z","date":"2018-06-29","kind":"purchase","acquired":true,"shares":2084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer issued these shares to the Reporting Person under the Director Compensation Plan."}],"balance_after":13218,"source":{"system":"sec-edgar","filing":"0001213900-18-008681","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008681/ownership.xml","form_type":"4"}},{"id":3882217,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T16:03:24.000Z","date":"2018-06-25","kind":"purchase","acquired":true,"shares":250,"price":10.72,"value":2680.0,"ownership":{"direct":true},"balance_after":11134,"source":{"system":"sec-edgar","filing":"0001213900-18-008317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008317/ownership.xml","form_type":"4"}},{"id":3882216,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T16:03:24.000Z","date":"2018-06-25","kind":"purchase","acquired":true,"shares":1100,"price":10.47,"value":11517.0,"ownership":{"direct":true},"balance_after":10884,"source":{"system":"sec-edgar","filing":"0001213900-18-008317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008317/ownership.xml","form_type":"4"}},{"id":3882215,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T16:03:24.000Z","date":"2018-06-22","kind":"purchase","acquired":true,"shares":50,"price":10.29,"value":514.5,"ownership":{"direct":true},"balance_after":9784,"source":{"system":"sec-edgar","filing":"0001213900-18-008317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008317/ownership.xml","form_type":"4"}},{"id":3882214,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T16:03:24.000Z","date":"2018-06-22","kind":"purchase","acquired":true,"shares":400,"price":10.35,"value":4140.0,"ownership":{"direct":true},"balance_after":9734,"source":{"system":"sec-edgar","filing":"0001213900-18-008317","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390018008317/ownership.xml","form_type":"4"}},{"id":4299793,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-05-03","kind":"purchase","acquired":true,"shares":1000,"price":0.75,"value":750.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299792,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-04-12","kind":"purchase","acquired":true,"shares":2000,"price":0.74,"value":1480.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299791,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-24","kind":"purchase","acquired":true,"shares":1000,"price":0.81,"value":810.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299790,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-23","kind":"purchase","acquired":true,"shares":1000,"price":0.81,"value":810.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299789,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-22","kind":"purchase","acquired":true,"shares":2000,"price":0.81,"value":1620.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299788,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-21","kind":"purchase","acquired":true,"shares":1000,"price":0.8,"value":800.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299787,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-20","kind":"purchase","acquired":true,"shares":1000,"price":0.81,"value":810.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299786,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-17","kind":"purchase","acquired":true,"shares":1000,"price":0.81,"value":810.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":19000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299785,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-16","kind":"purchase","acquired":true,"shares":2000,"price":0.82,"value":1640.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299784,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-14","kind":"purchase","acquired":true,"shares":1000,"price":0.85,"value":850.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299783,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-13","kind":"purchase","acquired":true,"shares":2000,"price":0.81,"value":1620.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299782,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-10","kind":"purchase","acquired":true,"shares":1000,"price":0.81,"value":810.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299781,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-06","kind":"purchase","acquired":true,"shares":1000,"price":0.85,"value":850.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299780,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-03-01","kind":"purchase","acquired":true,"shares":1000,"price":0.7,"value":700.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":11000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299779,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-28","kind":"purchase","acquired":true,"shares":1000,"price":0.71,"value":710.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299778,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-21","kind":"purchase","acquired":true,"shares":1000,"price":0.75,"value":750.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299777,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-15","kind":"purchase","acquired":true,"shares":1000,"price":0.77,"value":770.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299776,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-10","kind":"purchase","acquired":true,"shares":2000,"price":0.7,"value":1400.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299775,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-09","kind":"purchase","acquired":true,"shares":2000,"price":0.75,"value":1500.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299774,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-08","kind":"purchase","acquired":true,"shares":1000,"price":0.73,"value":730.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299773,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-08","kind":"purchase","acquired":true,"shares":1000,"price":0.76,"value":760.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}},{"id":4299772,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":33187,"kind":"person","name":"Vos Ellen O'Connor","position":1,"cik":"0001534357","reported_name":"Vos Ellen O'Connor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T20:30:41.000Z","date":"2017-02-06","kind":"purchase","acquired":true,"shares":1000,"price":0.77,"value":770.0,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001213900-17-006023","document":"f4020617vos_optimizerx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390017006023/f4020617vos_optimizerx.xml","form_type":"4"}}]}